DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc.

8.95
USD
-0.21
(-2.35%)
-0.61EPS
1.76BMarket Cap
Mar 04Next Earn
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
(Nasdaq Stock Market)

Recent

price

8.95

P/E

ratio

- -

div

yld

3.58%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
15.43
17.95
20.64
20.68
20.62
19.1
17.18
17.41
17.77
18.03
15.23
19.37
18.2
18.7
18.67
18.46
17.91
Revenue per Share
1.85
1.73
2.22
2.2
2.28
1.79
1.97
-6.76
-4.51
1.15
-0.33
1.88
-4.41
-0.62
-4.48
-3
-0.61
Basic EPS, GAAP
2.61
2.76
2.58
2.92
3.91
3.55
2.58
2.59
2.21
2.86
2.96
3.01
2.4
1.78
2.27
1.18
1.36
Free Cash Flow per Basic Share
0.2
0.2
0.22
0.24
0.26
0.29
0.3
0.34
0.35
0.36
0.4
0.42
0.48
0.55
0.62
0.64
0.32
Dividend per Share
12.97
13.04
15.52
17.81
16.47
16.69
35.26
29.17
22.96
23.01
22.55
22.98
17.7
15.89
9.77
6.71
6.8
Book Value per Share
3.23
-8
-5.85
-3.81
-3.11
-1.79
-3.46
-3.19
-3.28
-2.17
-7.12
-5.98
-3.62
-4.1
-4.34
-3.92
-2.99
Tangible Book Value per Share
144
141
142
143
142
140
218
229
224
223
219
218
216
212
203
199
200
Basic Weighted Avg Shares
2,221
2,538
2,928
2,951
2,923
2,674
3,745
3,993
3,986
4,022
3,339
4,231
3,922
3,965
3,793
3,680
3,575
Sales/Revenue/Turnover
17.62
13.26
13.92
14.66
15.63
16.45
12.76
12.87
8.76
10.79
6.92
14.77
9.28
7.29
4.96
6.85
4.9
Operating Margin (%)
66
85
129
128
129
123
272
316
331
323
334
346
328
343
349
352
339
Depreciation Expense
266
245
314
313
323
251
430
-1,550
-1,011
256
-73
411
-950
-132
-910
-598
-121
Net Income, GAAP
24.95
4.3
2.7
14.13
20.05
23.35
2.15
- -
- -
24.26
- -
24.59
- -
- -
- -
- -
- -
Effective Tax Rate (%)
11.96
9.64
10.73
10.61
11.05
9.39
11.48
-38.81
-25.36
6.36
-2.19
9.71
-24.22
-3.33
-23.99
-16.25
-3.38
Profit Margin (%)
955
289
183
347
554
721
976
1,048
875
1,005
426
591
723
548
157
680
761
Working Capital
604
1,490
1,222
1,166
1,150
1,141
1,511
1,612
1,565
1,553
2,108
2,062
1,975
1,921
1,677
2,108
2,072
LT Debt
1,910
1,884
2,249
2,578
2,322
2,339
8,126
6,628
5,133
5,095
4,935
4,997
3,812
3,294
1,943
1,340
1,354
Total Equity
11.59
9.29
9.95
9.14
9.27
8.06
6.72
- -
- -
3.94
- -
6.2
- -
- -
- -
- -
- -
Return on Invested Capital (%)
11.55
9.19
9.84
8.97
9.44
8.31
7.05
- -
- -
4.1
- -
6.23
- -
- -
- -
- -
- -
Return on Capital (%)
14.47
13.26
15.49
13.2
13.3
10.78
8.23
-21.04
-17.23
5.01
-1.46
8.28
-21.57
-3.72
-34.77
-36.45
-8.54
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
230
228
215
LT Borrowings
2,006
1,996
1,985
LT Finance Leases
95
88
87
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
200
199
199
Market Capitalization
2,323
2,114
1,765

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,845
1,928
1,978
Cash, Cash Equivalents & STI
190
239
195
Accounts Receivable, Net
622
620
605
Inventories
659
665
707
Total Current Liabilities
1,207
1,185
1,217
Payables & Accruals
977
957
1,002
ST Debt
230
228
215
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.44%
-21.62%
-31.03%
Free Cash Flow
-4.12%
-14.78%
-49.02%
Net Income, GAAP
-120.32%
-105.03%
-34.29%
Sales/Revenue/Turnover
4.36%
2.64%
-2.98%
Total Cash Common Dividend
13.41%
7.87%
1.59%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
953
984
951
905
3,793
2025
879
936
904
961
3,680
2026
880
898
836
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
-0.02
-2.46
-2.16
-4.48
2025
0.1
-0.23
-2.14
-0.73
-3
2026
-0.05
0.19
-0.01
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
0.16
0.16
0.16
0.62
2025
0.16
0.16
0.16
0.16
0.64
2026
0.16
- -
- -
- -
- -
Business
DENTSPLY SIRONA Inc. DENTSPLY SIRONA Inc. develops, manufactures, and markets a comprehensive portfolio of professional dental products and technologies worldwide, serving dental professionals, laboratories, clinics, and distributors in more than 150 countries. The company, formed by the 2016 merger of DENTSPLY International (founded in 1899 in New York City) and Sirona Dental Systems (founded in 1877 in Erlangen, Germany) and headquartered in Charlotte, North Carolina, offers end-to-end solutions including CAD/CAM systems such as CEREC Primescan, Primemill, and inLab; digital imaging with Orthophos, GALILEOS, and XIOS sensors; treatment centers like Axano, INTEGO, and SINIUS; implants via Astra Tech, Ankylos, and DS OmniTaper systems; consumables encompassing restoratives (SureFil, Celtra Duo, Spectra), endodontics (ProTaper Ultimate, WaveOne Gold, TruNatomy), orthodontics (SureSmile aligners), and infection prevention products; laboratory equipment including CEREC Speedfire furnaces and inFire HTC; handpieces and instruments under the Midwest brand; hygiene systems like DAC Universal; and healthcare consumables through Wellspect such as urological catheters. DENTSPLY SIRONA Inc. operates across key segments including connected technology solutions, essential dental equipment, and consumables, targeting general dentists, specialists, oral surgeons, periodontists, endodontists, and orthodontic practices with a focus on digital dentistry, innovation, and clinical education. In recent strategic developments, the company completed a review of alternatives for its Wellspect Healthcare subsidiary in September 2025 and elected to retain it for enhanced long-term value, amid a multi-year transformation emphasizing operational efficiencies, customer engagement, and portfolio optimization; appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer in October 2025 to strengthen commercial leadership and align business units; launched innovations like Primescan 2, DS Core platform, Primeprint 3D printing solutions, and enhancements to SureSmile aligners and X-Smart Pro+ endodontic motor; and expanded clinical education through DS World events and DS Academy Campus while advancing sustainability initiatives under the BEYOND program and partnerships like Smile Train.

Company News

  • New Strong Sell Stocks for November 13th

  • DENTSPLY SIRONA Inc. (XRAY) Q3 2026 Earnings Call Transcript

  • DENTSPLY SIRONA Q3 Earnings Call Highlights

  • XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut

  • Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

  • Dentsply International (XRAY) Q3 Earnings and Revenues Miss Estimates

  • Dentsply Sirona Reports Third Quarter 2026 Results

  • DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?

  • Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5

  • Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal

  • Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendments

  • Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

  • Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement

  • DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell?

  • Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY

  • Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now

  • XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

  • Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference